Chinese version of Website (中国版网站)
Search
Advanced Search
Chinese version of Website (中国版网站)
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2019
Price and Ordering Information
Subscription Rates 2018
Subscription Rates 2017
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
eBooks Website
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Bentham Online
Bentham Insight
Online Feedback
Purchase Articles
Search Articles
Social Media
Submit Manuscripts
Marketing Opportunities
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2018
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Kudos
Media Partners
Partnering Events
For Librarians
FAQ’s for e-prints/reprints
Journal Catalog 2018
Library Recommendations
Order Bulk ePrints
Order Bulk Reprints
Table of Contents Alert
Trial Requests
For Authors & Editors
Author Benefits
Author's Benefits Guide
Editorial Policies
General FAQ’s
Guidelines for Guest Editors
Online Manuscript Submission
Journal Catalog 2018
Publication Cycle - Process Flowchart
Publishing Ethics
Reviewer Guidelines
Self-Archiving Policies
Table of Contents Alert
Contact
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
Volume 24, 46 Issues, 2018
Download PDF Flyer
Current Pharmaceutical Design
This journal supports open access
Impact Factor:
2.611
5 - Year Impact Factor:
3
Aims & Scope
Abstracted/Indexed in
Submit Abstracts Online
Submit Manuscripts Online
Editor-in-Chief:
William A. Banks
VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA
View Full Editorial Board
Subscribe
Purchase Articles
Order Reprints
Journal Home
Editorial Policies
Publishing Ethics
Self-Archiving Policies
Reviewer Guidelines
Instructions for Authors
Free Copies Online
Contents & Abstracts
Open Access Articles
Most Accessed Articles
Most Cited Articles
Advertise With Us
Library Recommendation
Trial Requests
More Options
Special Issue Submission
Thematic Issues
Open Access Funding
Advertisement
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
Volume 24, 46 Issues, 2018
Download PDF Flyer
Current Pharmaceutical Design
This journal supports open access
Impact Factor:
2.611
5 - Year Impact Factor:
3
Aims & Scope
Abstracted/Indexed in
Submit Abstracts Online
Submit Manuscripts Online
Editor-in-Chief:
William A. Banks
VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA
View Full Editorial Board
Subscribe
Purchase Articles
Order Reprints
Journal Home
Editorial Policies
Publishing Ethics
Self-Archiving Policies
Reviewer Guidelines
Instructions for Authors
Free Copies Online
Contents & Abstracts
Open Access Articles
Most Accessed Articles
Most Cited Articles
Advertise With Us
Library Recommendation
Trial Requests
More Options
Special Issue Submission
Thematic Issues
Open Access Funding
Current Pharmaceutical Design
This journal supports open access
Quick Links
Journal Home
Editorial Policies
Publishing Ethics
Self-Archiving Policies
Reviewer Guidelines
Instructions for Authors
Free Copies Online
Contents & Abstracts
Open Access Articles
Most Accessed Articles
Most Cited Articles
Advertise With Us
Library Recommendation
Trial Requests
Special Issue Submission
Thematic Issues
Open Access Funding
Impact Factor:
2.611
5 - Year Impact Factor:
3
Aims & Scope
Abstracted/Indexed in
Submit Abstracts Online
More Options
Submit Manuscripts Online
Editor-in-Chief:
William A. Banks
VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA
View Full Editorial Board
Subscribe
More Options
Purchase Articles
Order Reprints
Contents
Current Pharmaceutical Design
,
Volume 17
- Number 2
Editorial [Hot topic:Novel Potential Therapeutic Approaches for Schizophrenia (Executive Guest Editor: Kenji Hashimoto)]
,
17
(
2
):
92
- 93
Kenji Hashimoto
DOI:
10.2174/1381612811109020092
Permissions
Order Reprints
Order Eprints
Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia
,
17
(
2
):
94
- 102
Shigeyuki Chaki and Hirohiko Hikichi
DOI:
10.2174/138161211795049570
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia
,
17
(
2
):
103
- 111
Dana V. Ferraris and Takashi Tsukamoto
DOI:
10.2174/138161211795049633
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia
,
17
(
2
):
112
- 120
Kenji Hashimoto
DOI:
10.2174/138161211795049598
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
α7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia
,
17
(
2
):
121
- 129
Masatomo Ishikawa and Kenji Hashimoto
DOI:
10.2174/138161211795049561
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Kynurenine Pathway in Schizophrenia: Pathophysiological and Therapeutic Aspects
,
17
(
2
):
130
- 136
Norbert Muller, Aye-Mu Myint and Markus J. Schwarz
DOI:
10.2174/138161211795049552
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia
,
17
(
2
):
137
- 150
Jan Kehler and Jacob Nielsen
DOI:
10.2174/138161211795049624
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
,
17
(
2
):
151
- 167
Silvia Paba, Roberto Frau, Sean C. Godar, Paola Devoto, Francesco Marrosu and Marco Bortolato
DOI:
10.2174/138161211795049589
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Role of Polyunsaturated Fatty Acids and Fatty Acid Binding Protein in the Pathogenesis of Schizophrenia
,
17
(
2
):
168
- 175
Motoko Maekawa, Yuji Owada and Takeo Yoshikawa
DOI:
10.2174/138161211795049615
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
MicroRNAs: A Novel Therapeutic Target for Schizophrenia
,
17
(
2
):
176
- 188
Javier A. Bravo and Timothy G. Dinan
DOI:
10.2174/138161211795049543
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Webmaster Contact:
info@benthamscience.org
Copyright © 2018 Bentham Science